{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:35:47Z","timestamp":1772771747843,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"President's Fund of Nanfang Hospital, Southern Medical University","award":["2022A034"],"award-info":[{"award-number":["2022A034"]}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["2022A1515110656"],"award-info":[{"award-number":["2022A1515110656"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01956-y","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:10:01Z","timestamp":1739790601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Purine metabolism-associated key genes depict the immune landscape in gout patients"],"prefix":"10.1007","volume":"16","author":[{"given":"Lin-na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-shan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-nan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"8","key":"1956_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41584-024-01137-1","volume":"20","author":"MP Leask","year":"2024","unstructured":"Leask MP, Crisan TO, Ji A, Matsuo H, Kottgen A, Merriman TR. The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies. Nat Rev Rheumatol. 2024;20(8):510\u201323. https:\/\/doi.org\/10.1038\/s41584-024-01137-1.","journal-title":"Nat Rev Rheumatol"},{"issue":"31","key":"1956_CR2","doi-asserted-by":"publisher","first-page":"18175","DOI":"10.1073\/pnas.2006958117","volume":"117","author":"Y Toyoda","year":"2020","unstructured":"Toyoda Y, et al. Identification of GLUT12\/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice. Proc Natl Acad Sci U S A. 2020;117(31):18175\u20137. https:\/\/doi.org\/10.1073\/pnas.2006958117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1956_CR3","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2147\/IJGM.S355253","volume":"15","author":"R Li","year":"2022","unstructured":"Li R, et al. Tea consumption is associated with an increased risk of hyperuricemia in an occupational population in Guangdong, China. Int J Gen Med. 2022;15:2747\u201357. https:\/\/doi.org\/10.2147\/IJGM.S355253.","journal-title":"Int J Gen Med"},{"key":"1956_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404047","author":"L Zeng","year":"2024","unstructured":"Zeng L, et al. Multimodal machine learning-based marker enables early detection and prognosis prediction for hyperuricemia. Adv Sci (Weinh). 2024. https:\/\/doi.org\/10.1002\/advs.202404047.","journal-title":"Adv Sci (Weinh)"},{"key":"1956_CR5","doi-asserted-by":"publisher","first-page":"124664","DOI":"10.1016\/j.envpol.2024.124664","volume":"360","author":"X Ding","year":"2024","unstructured":"Ding X, et al. Cross-sectional and longitudinal associations of PAHs exposure with serum uric acid and hyperuricemia among Chinese urban residents: the potential role of oxidative damage. Environ Pollut. 2024;360:124664. https:\/\/doi.org\/10.1016\/j.envpol.2024.124664.","journal-title":"Environ Pollut"},{"key":"1956_CR6","doi-asserted-by":"publisher","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","volume":"14","author":"YR Liu","year":"2023","unstructured":"Liu YR, Wang JQ, Li J. Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front Immunol. 2023;14:1137822. https:\/\/doi.org\/10.3389\/fimmu.2023.1137822.","journal-title":"Front Immunol"},{"key":"1956_CR7","doi-asserted-by":"publisher","first-page":"1367019","DOI":"10.3389\/fimmu.2024.1367019","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Identification of potential biomarkers of gout through weighted gene correlation network analysis. Front Immunol. 2024;15:1367019. https:\/\/doi.org\/10.3389\/fimmu.2024.1367019.","journal-title":"Front Immunol"},{"issue":"6","key":"1956_CR8","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/cpt.3229","volume":"115","author":"IG Asiimwe","year":"2024","unstructured":"Asiimwe IG, Walker L, Sofat R, Jorgensen AL, Pirmohamed M. Genetic determinants of thiazide-induced hyperuricemia, hyperglycemia, and urinary electrolyte disturbances\u2014a genome-wide evaluation of the UK Biobank. Clin Pharmacol Ther. 2024;115(6):1408\u201317. https:\/\/doi.org\/10.1002\/cpt.3229.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1956_CR9","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1038\/s41467-024-50752-9","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA. Nat Commun. 2024;15(1):6463. https:\/\/doi.org\/10.1038\/s41467-024-50752-9.","journal-title":"Nat Commun"},{"issue":"9","key":"1956_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/annrheumdis-2020-219796","volume":"80","author":"G Sandoval-Plata","year":"2021","unstructured":"Sandoval-Plata G, Morgan K, Abhishek A. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank. Ann Rheum Dis. 2021;80(9):1220\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219796.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1956_CR11","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1038\/s41467-024-47805-4","volume":"15","author":"C Cho","year":"2024","unstructured":"Cho C, et al. Large-scale cross-ancestry genome-wide meta-analysis of serum urate. Nat Commun. 2024;15(1):3441. https:\/\/doi.org\/10.1038\/s41467-024-47805-4.","journal-title":"Nat Commun"},{"key":"1956_CR12","doi-asserted-by":"publisher","first-page":"1434118","DOI":"10.3389\/fimmu.2024.1434118","volume":"15","author":"Y Han","year":"2024","unstructured":"Han Y, Dong C, Hu M, Wang X, Wang G. Unlocking the adenosine receptor mechanism of the tumour immune microenvironment. Front Immunol. 2024;15:1434118. https:\/\/doi.org\/10.3389\/fimmu.2024.1434118.","journal-title":"Front Immunol"},{"issue":"23","key":"1956_CR13","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood.2021011234","volume":"139","author":"Q Ma","year":"2022","unstructured":"Ma Q, et al. Soluble uric acid inhibits beta2 integrin-mediated neutrophil recruitment in innate immunity. Blood. 2022;139(23):3402\u201317. https:\/\/doi.org\/10.1182\/blood.2021011234.","journal-title":"Blood"},{"key":"1956_CR14","doi-asserted-by":"publisher","first-page":"1074867","DOI":"10.3389\/fimmu.2022.1074867","volume":"13","author":"H Wu","year":"2022","unstructured":"Wu H, Wang Y, Ren Z, Li Y, Huang J, Lin Z, Zhang B. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail. Front Immunol. 2022;13:1074867. https:\/\/doi.org\/10.3389\/fimmu.2022.1074867.","journal-title":"Front Immunol"},{"key":"1956_CR15","doi-asserted-by":"publisher","first-page":"1387582","DOI":"10.3389\/fimmu.2024.1387582","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu M, Lu M, Luo L, Han Z, Liu X. Exploring the impact of m(6)A modification on immune diseases: mechanisms and therapeutic implication. Front Immunol. 2024;15:1387582. https:\/\/doi.org\/10.3389\/fimmu.2024.1387582.","journal-title":"Front Immunol"},{"key":"1956_CR16","doi-asserted-by":"publisher","first-page":"1282890","DOI":"10.3389\/fimmu.2023.1282890","volume":"14","author":"D Li","year":"2023","unstructured":"Li D, et al. The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. Front Immunol. 2023;14:1282890. https:\/\/doi.org\/10.3389\/fimmu.2023.1282890.","journal-title":"Front Immunol"},{"issue":"1","key":"1956_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cmet.2021.12.009","volume":"34","author":"S Saveljeva","year":"2022","unstructured":"Saveljeva S, et al. A purine metabolic checkpoint that prevents autoimmunity and autoinflammation. Cell Metab. 2022;34(1):106\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.009.","journal-title":"Cell Metab"},{"key":"1956_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171417","author":"H Yu","year":"2023","unstructured":"Yu H, et al. Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.171417.","journal-title":"JCI Insight"},{"issue":"3","key":"1956_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41423-023-01121-x","volume":"21","author":"KG Lee","year":"2024","unstructured":"Lee KG, Hong BK, Lee S, Lee N, Kim SW, Kim D, Kim WU. Nuclear receptor coactivator 6 is a critical regulator of NLRP3 inflammasome activation and gouty arthritis. Cell Mol Immunol. 2024;21(3):227\u201344. https:\/\/doi.org\/10.1038\/s41423-023-01121-x.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"1956_CR20","doi-asserted-by":"publisher","first-page":"113139","DOI":"10.1016\/j.celrep.2023.113139","volume":"42","author":"H Gu","year":"2023","unstructured":"Gu H, et al. MSU crystal deposition contributes to inflammation and immune responses in gout remission. Cell Rep. 2023;42(10):113139. https:\/\/doi.org\/10.1016\/j.celrep.2023.113139.","journal-title":"Cell Rep"},{"issue":"7","key":"1956_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard-2023-225305","volume":"83","author":"HK Ea","year":"2024","unstructured":"Ea HK, et al. Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker. Ann Rheum Dis. 2024;83(7):945\u201356. https:\/\/doi.org\/10.1136\/ard-2023-225305.","journal-title":"Ann Rheum Dis"},{"key":"1956_CR22","doi-asserted-by":"publisher","first-page":"1045982","DOI":"10.3389\/fimmu.2022.1045982","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei Y, Cui TJ, Wang XH, Zhang XM, Tang C, Zheng ZH. Plasma adsorption in refractory chronic gouty arthritis flare: a case report. Front Immunol. 2022;13:1045982. https:\/\/doi.org\/10.3389\/fimmu.2022.1045982.","journal-title":"Front Immunol"},{"key":"1956_CR23","doi-asserted-by":"publisher","first-page":"123783","DOI":"10.1016\/j.ijbiomac.2023.123783","volume":"235","author":"AA Abbas","year":"2023","unstructured":"Abbas AA, Abdulkader HA, Giordo R, Ashour HM, Erre GL, Pintus G, Zayed H. Implications and theragnostic potentials of circular RNAs in rheumatic diseases. Int J Biol Macromol. 2023;235:123783. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123783.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"1956_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-024-06931-z","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao L, et al. Role of N6-methyladenosine in tumor neovascularization. Cell Death Dis. 2024;15(8):563. https:\/\/doi.org\/10.1038\/s41419-024-06931-z.","journal-title":"Cell Death Dis"},{"key":"1956_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009281","author":"M Yang","year":"2024","unstructured":"Yang M, et al. NAD(+) metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-009281.","journal-title":"J Immunother Cancer"},{"key":"1956_CR26","doi-asserted-by":"publisher","first-page":"1374465","DOI":"10.3389\/fimmu.2024.1374465","volume":"15","author":"S Xu","year":"2024","unstructured":"Xu S, Zhang Y, Yang Y, Dong K, Zhang H, Luo C, Liu SM. A m(6)A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma. Front Immunol. 2024;15:1374465. https:\/\/doi.org\/10.3389\/fimmu.2024.1374465.","journal-title":"Front Immunol"},{"key":"1956_CR27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz068","author":"L Hu","year":"2020","unstructured":"Hu L, et al. U-shaped association of serum uric acid with all-cause and cause-specific mortality in US adults: a cohort study. J Clin Endocrinol Metab. 2020. https:\/\/doi.org\/10.1210\/clinem\/dgz068.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1956_CR28","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S2352-3026(19)30253-4","volume":"7","author":"FP Tambaro","year":"2020","unstructured":"Tambaro FP, Wierda WG. Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations. Lancet Haematol. 2020;7(2):e168\u201376. https:\/\/doi.org\/10.1016\/S2352-3026(19)30253-4.","journal-title":"Lancet Haematol"},{"issue":"1","key":"1956_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ajh.26395","volume":"97","author":"K Sasaki","year":"2022","unstructured":"Sasaki K, et al. Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. Am J Hematol. 2022;97(1):68\u201378. https:\/\/doi.org\/10.1002\/ajh.26395.","journal-title":"Am J Hematol"},{"issue":"8","key":"1956_CR30","doi-asserted-by":"publisher","first-page":"14364","DOI":"10.1002\/jcp.28138","volume":"234","author":"Y Xie","year":"2019","unstructured":"Xie Y, et al. Hyperuricemia and gout are associated with cancer incidence and mortality: a meta-analysis based on cohort studies. J Cell Physiol. 2019;234(8):14364\u201376. https:\/\/doi.org\/10.1002\/jcp.28138.","journal-title":"J Cell Physiol"},{"key":"1956_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101070","volume":"21","author":"MG Battelli","year":"2019","unstructured":"Battelli MG, Bortolotti M, Polito L, Bolognesi A. Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase. Redox Biol. 2019;21: 101070. https:\/\/doi.org\/10.1016\/j.redox.2018.101070.","journal-title":"Redox Biol"},{"issue":"6","key":"1956_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/iub.1154","volume":"65","author":"P Chen","year":"2013","unstructured":"Chen P, Li J, Ma J, Teng M, Li X. A small disturbance, but a serious disease: the possible mechanism of D52H-mutant of human PRS1 that causes gout. IUBMB Life. 2013;65(6):518\u201325. https:\/\/doi.org\/10.1002\/iub.1154.","journal-title":"IUBMB Life"},{"issue":"10","key":"1956_CR33","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1002\/ajmg.a.38359","volume":"173","author":"J Porrmann","year":"2017","unstructured":"Porrmann J, et al. Novel PRPS1 gain-of-function mutation in a patient with congenital hyperuricemia and facial anomalies. Am J Med Genet A. 2017;173(10):2736\u201342. https:\/\/doi.org\/10.1002\/ajmg.a.38359.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1956_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2021.12.016","volume":"136","author":"JP Dewulf","year":"2022","unstructured":"Dewulf JP, Marie S, Nassogne MC. Disorders of purine biosynthesis metabolism. Mol Genet Metab. 2022;136(3):190\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.016.","journal-title":"Mol Genet Metab"},{"key":"1956_CR35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.omtn.2023.02.009","volume":"31","author":"G Jang","year":"2023","unstructured":"Jang G, et al. Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing. Mol Ther Nucleic Acids. 2023;31:586\u201395. https:\/\/doi.org\/10.1016\/j.omtn.2023.02.009.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"1956_CR36","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","volume":"56","author":"B Stiburkova","year":"2017","unstructured":"Stiburkova B, et al. Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology (Oxford). 2017;56(11):1982\u201392. https:\/\/doi.org\/10.1093\/rheumatology\/kex295.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1956_CR37","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","volume":"11","author":"KM Hoque","year":"2020","unstructured":"Hoque KM, et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nat Commun. 2020;11(1):2767. https:\/\/doi.org\/10.1038\/s41467-020-16525-w.","journal-title":"Nat Commun"},{"key":"1956_CR38","doi-asserted-by":"publisher","first-page":"1045805","DOI":"10.3389\/fnut.2022.1045805","volume":"9","author":"P Zhang","year":"2022","unstructured":"Zhang P, et al. Dietary intake of fructose increases purine de novo synthesis: a crucial mechanism for hyperuricemia. Front Nutr. 2022;9:1045805. https:\/\/doi.org\/10.3389\/fnut.2022.1045805.","journal-title":"Front Nutr"},{"issue":"15","key":"1956_CR39","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1242\/dev.038315","volume":"136","author":"A Ng","year":"2009","unstructured":"Ng A, Uribe RA, Yieh L, Nuckels R, Gross JM. Zebrafish mutations in gart and paics identify crucial roles for de novo purine synthesis in vertebrate pigmentation and ocular development. Development. 2009;136(15):2601\u201311. https:\/\/doi.org\/10.1242\/dev.038315.","journal-title":"Development"},{"key":"1956_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940228","volume":"13","author":"J Cao","year":"2022","unstructured":"Cao J, Liu Q, Hao H, Bu Y, Tian X, Wang T, Yi H. Lactobacillus paracasei X11 ameliorates hyperuricemia and modulates gut microbiota in mice. Front Immunol. 2022;13: 940228. https:\/\/doi.org\/10.3389\/fimmu.2022.940228.","journal-title":"Front Immunol"},{"key":"1956_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","volume":"37","author":"J Linden","year":"2019","unstructured":"Linden J, Koch-Nolte F, Dahl G. Purine release, metabolism, and signaling in the inflammatory response. Annu Rev Immunol. 2019;37:325\u201347. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052406.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1956_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/cs0670249","volume":"67","author":"KD MacDermot","year":"1984","unstructured":"MacDermot KD, Allsop J, Watts RW. The rate of purine synthesis de nova in blood mononuclear cells in vitro from patients with familial hyperuricaemic nephropathy. Clin Sci (Lond). 1984;67(2):249\u201358. https:\/\/doi.org\/10.1042\/cs0670249.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1956_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/imm.13608","volume":"169","author":"L Leikeim","year":"2023","unstructured":"Leikeim L, et al. Adenosine signalling in T-cell activation favours development of IL-17 positive cells with suppressive properties. Immunology. 2023;169(1):42\u201356. https:\/\/doi.org\/10.1111\/imm.13608.","journal-title":"Immunology"},{"issue":"2","key":"1956_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pharmthera.2006.08.003","volume":"113","author":"G Hasko","year":"2007","unstructured":"Hasko G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther. 2007;113(2):264\u201375. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.08.003.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1956_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imr.12833","volume":"294","author":"G Cabau","year":"2020","unstructured":"Cabau G, Crisan TO, Kluck V, Popp RA, Joosten LAB. Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia. Immunol Rev. 2020;294(1):92\u2013105. https:\/\/doi.org\/10.1111\/imr.12833.","journal-title":"Immunol Rev"},{"issue":"4","key":"1956_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00281-013-0361-0","volume":"35","author":"I Mitroulis","year":"2013","unstructured":"Mitroulis I, Kambas K, Ritis K. Neutrophils, IL-1beta, and gout: is there a link? Semin Immunopathol. 2013;35(4):501\u201312. https:\/\/doi.org\/10.1007\/s00281-013-0361-0.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"1956_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tips.2021.10.010","volume":"43","author":"L Antonioli","year":"2022","unstructured":"Antonioli L, Pacher P, Hasko G. Adenosine and inflammation: it\u2019s time to (re)solve the problem. Trends Pharmacol Sci. 2022;43(1):43\u201355. https:\/\/doi.org\/10.1016\/j.tips.2021.10.010.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"1956_CR48","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/annrheumdis-2020-217342","volume":"79","author":"F Renaudin","year":"2020","unstructured":"Renaudin F, et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1beta activation on macrophages. Ann Rheum Dis. 2020;79(11):1506\u201314. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217342.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1956_CR49","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1093\/rheumatology\/keab335","volume":"60","author":"C Diaz-Torne","year":"2021","unstructured":"Diaz-Torne C, et al. The inflammatory role of silent urate crystal deposition in intercritical gout. Rheumatology (Oxford). 2021;60(11):5463\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/keab335.","journal-title":"Rheumatology (Oxford)"},{"key":"1956_CR50","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3389\/fimmu.2017.01260","volume":"8","author":"JH Jeong","year":"2017","unstructured":"Jeong JH, et al. CD14(+) cells with the phenotype of infiltrated monocytes consist of distinct populations characterized by anti-inflammatory as well as pro-inflammatory activity in gouty arthritis. Front Immunol. 2017;8:1260. https:\/\/doi.org\/10.3389\/fimmu.2017.01260.","journal-title":"Front Immunol"},{"issue":"1","key":"1956_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2020.10.021","volume":"33","author":"H Lv","year":"2021","unstructured":"Lv H, et al. NAD(+) metabolism maintains inducible PD-L1 expression to drive tumor immune evasion. Cell Metab. 2021;33(1):110\u201327. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.021.","journal-title":"Cell Metab"},{"key":"1956_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061602","author":"N Ludwig","year":"2020","unstructured":"Ludwig N, Gillespie DG, Reichert TE, Jackson EK, Whiteside TL. Purine metabolites in tumor-derived exosomes may facilitate immune escape of head and neck squamous cell carcinoma. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12061602.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1956_CR53","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1136\/ard.2010.145821","volume":"70","author":"YH Chen","year":"2011","unstructured":"Chen YH, et al. Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFbeta1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis. 2011;70(9):1655\u201363. https:\/\/doi.org\/10.1136\/ard.2010.145821.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1956_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","volume":"14","author":"TJ Major","year":"2018","unstructured":"Major TJ, Dalbeth N, Stahl EA, Merriman TR. An update on the genetics of hyperuricaemia and gout. Nat Rev Rheumatol. 2018;14(6):341\u201353. https:\/\/doi.org\/10.1038\/s41584-018-0004-x.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01956-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01956-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01956-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:10:06Z","timestamp":1739790606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01956-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01956-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}